SCHEMBL7708592

SCHEMBL7708592

Nc1ncc(Oc2cccc(Cl)c2)c(=O)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
EGFR P00533 1/20 0.41
XDH P47989 1/20 0.41
LMNA P02545 1/20 0.41
ICAM1 P05362 1/20 0.41
SELE P16581 1/20 0.41
VCAM1 P19320 1/20 0.41
PTGS1 P23219 2/20 0.41
PTGS2 P35354 1/20 0.41
SLC9A1 P19634 1/20 0.40
MAP4K4 O95819 1/20 0.40
LTA4H P09960 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CDK8 P49336 1/20 0.39
SLC6A4 P31645 1/20 0.39
MEN1 O00255 1/20 0.39
PPP1CA P62136 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7712364 0.83 USP2 (0.45) MAP4K4SLC6A4KMT2A
SCHEMBL7712437 0.83 ALDH1A1 (0.50) CYP1A2CYP2C9CYP2C19XDHLMNA
SCHEMBL7712389 0.83 MAPT (0.49) XDHLMNAL3MBTL1MEN1KMT2A
SCHEMBL5202998 0.82 LTA4H (0.57) CYP1A2CYP2C9CYP2C19XDHLTA4H
SCHEMBL5206240 0.82 NOS1 (0.45) XDHLMNALTA4H
SCHEMBL5206842 0.79 MEN1 (0.53) RHEBCYP1A2CYP2C9LMNAPTGS1
SCHEMBL5204487 0.79 SOS1 (0.40) LMNAMAP4K4LTA4HSLC6A4KMT2A
SCHEMBL7714270 0.77 CYP1A2 (0.47) CYP1A2CYP2C19LMNAICAM1SELE
SCHEMBL5206393 0.77 MEN1 (0.39) PTGS1PTGS2LTA4HSLC6A4MEN1
SCHEMBL7712415 0.75 ALDH1A1 (0.41) XDHLMNAPTGS1PTGS2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed